XENERGY INC (XE)

NASDAQIndustrialsIndustrial - MachinerySnapshot 2026-10-23

$10.60-0.28%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge XENERGY INC’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	53.24M
EPS	—	-0.095
Annual ending 2026-12-31
Revenue	—	214.84M
EPS	—	-0.756
Annual ending 2027-12-31
Revenue	—	858.43M
EPS	—	-0.436

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
reduce losses from -$0.47 EPS in FY 2026 toward breakeven	A primary condition in XENERGY INC's published investment case. The stated target is EPS trending toward breakeven from -$0.47 in FY 2026.	Broken	EPS worsens beyond -$0.50 in FY 2027	Diluted EPS: $-0.21 per share FY2026-Q2; GAAP. Published target: EPS trending toward breakeven from -$0.47 in FY 2026. Target period is not explicitly aligned with this observation. Source published Aug 13, 2026-0.21 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
grow revenue from ~$80M in Q3 2026 to >$850M in FY 2027	A primary condition in XENERGY INC's published investment case. The stated target is >= $850M revenue in FY 2027.	Broken	revenue falls below $212M in FY 2026 or fails to grow toward $850M in FY 2027	Revenue: $54.601M FY2026-Q2; GAAP. Published target: >= $850M revenue in FY 2027. Target period is not explicitly aligned with this observation. Source published Aug 13, 202654,601,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: d2212ae3-0bf6-46de-9e6d-0e21ae427c81. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
successful deployment and acceptance of Xe-100 small modular reactor technology	X-Energy leads in clean energy with its Xe-100 small modular reactor.	Intact	significant delays or failures in technology deployment reported	Qualitative: 12 reactors planned, NRC target Q1 '27 Amazon/AEP 12-reactor deal and Q1 '27 NRC permit target reinforce deployment progress. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenue$0.86B

$0.76B → $0.86B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	$758,303,844	3 / 5
2026-07-25	Unavailable	$758,303,844	3 / 5
2026-07-26	Unavailable	$758,303,844	3 / 5
2026-07-27	Unavailable	$758,303,844	3 / 5
2026-07-28	Unavailable	$758,303,844	3 / 5
2026-07-29	Unavailable	$758,303,844	3 / 5
2026-07-30	Unavailable	$758,303,844	3 / 5
2026-07-31	Unavailable	$858,236,620	3 / 7
2026-08-01	Unavailable	$758,303,844	3 / 5
2026-08-02	Unavailable	$758,303,844	3 / 5
2026-08-03	Unavailable	$858,236,620	3 / 7
2026-08-04	Unavailable	$758,303,844	3 / 5
2026-08-05	Unavailable	$758,303,844	3 / 5
2026-08-06	Unavailable	$758,303,844	3 / 5
2026-08-08	Unavailable	$858,236,620	3 / 7
2026-08-09	Unavailable	$758,303,844	3 / 5
2026-08-10	Unavailable	$758,303,844	3 / 5
2026-08-12	Unavailable	$758,303,844	3 / 5
2026-08-13	Unavailable	$758,303,844	3 / 5
2026-08-14	Unavailable	$758,303,844	3 / 5
2026-08-15	Unavailable	$758,303,844	3 / 5
2026-08-16	Unavailable	$758,303,844	3 / 5
2026-08-17	Unavailable	$758,303,844	3 / 5
2026-08-18	Unavailable	$758,303,844	3 / 5
2026-08-19	Unavailable	$758,303,844	3 / 5
2026-08-20	Unavailable	$858,231,293	3 / 5
2026-08-21	Unavailable	$858,231,293	3 / 5
2026-08-22	Unavailable	$858,231,293	3 / 5
2026-08-23	Unavailable	$858,231,293	3 / 5
2026-08-24	Unavailable	$858,231,293	3 / 5
2026-08-25	Unavailable	$858,231,293	3 / 5
2026-08-26	Unavailable	$858,231,293	3 / 5
2026-08-27	Unavailable	$858,231,293	3 / 5
2026-08-28	Unavailable	$858,231,293	3 / 5
2026-08-29	Unavailable	$858,231,293	3 / 5
2026-08-30	Unavailable	$858,231,293	3 / 5
2026-08-31	Unavailable	$858,231,293	3 / 5
2026-09-01	Unavailable	$858,231,293	3 / 5
2026-09-02	Unavailable	$858,231,293	3 / 5
2026-09-03	Unavailable	$858,231,293	3 / 5
2026-09-04	Unavailable	$858,231,293	3 / 5
2026-09-05	Unavailable	$858,231,293	3 / 5
2026-09-06	Unavailable	$858,231,293	3 / 5
2026-09-07	Unavailable	$858,231,293	3 / 5
2026-09-08	Unavailable	$858,231,293	3 / 5
2026-09-09	Unavailable	$858,231,293	3 / 5
2026-09-10	Unavailable	$858,231,293	4 / 5
2026-09-11	Unavailable	$858,231,293	4 / 5
2026-09-12	Unavailable	$860,173,239	4 / 5
2026-09-13	Unavailable	$860,173,239	4 / 5
2026-09-14	Unavailable	$860,173,239	4 / 5
2026-09-15	Unavailable	$858,434,205	4 / 5
2026-09-16	Unavailable	$858,434,205	4 / 5
2026-09-17	Unavailable	$858,434,205	4 / 5
2026-09-18	Unavailable	$858,434,205	4 / 5
2026-09-19	Unavailable	$858,434,205	4 / 5
2026-09-20	Unavailable	$858,434,205	4 / 5
2026-09-21	Unavailable	$858,434,205	4 / 5
2026-09-22	Unavailable	$858,434,205	4 / 5
2026-09-23	Unavailable	$858,434,205	4 / 5
2026-09-24	Unavailable	$858,434,205	4 / 5
2026-09-25	Unavailable	$858,434,205	4 / 5
2026-09-26	Unavailable	$858,434,205	4 / 5
2026-09-27	Unavailable	$858,434,205	4 / 5
2026-09-28	Unavailable	$858,434,205	4 / 5
2026-09-29	Unavailable	$858,434,205	4 / 5
2026-09-30	Unavailable	$858,434,205	4 / 5
2026-10-01	Unavailable	$858,434,205	4 / 5
2026-10-02	Unavailable	$858,434,205	4 / 5
2026-10-03	Unavailable	$858,434,205	4 / 5
2026-10-04	Unavailable	$858,434,205	4 / 5
2026-10-05	Unavailable	$858,434,205	4 / 5
2026-10-06	Unavailable	$858,434,205	4 / 5
2026-10-07	Unavailable	$858,434,205	4 / 5
2026-10-08	Unavailable	$858,434,205	4 / 5
2026-10-09	Unavailable	$858,434,205	4 / 5
2026-10-10	Unavailable	$858,434,205	4 / 5
2026-10-11	Unavailable	$860,650,178	4 / 5
2026-10-12	Unavailable	$860,650,178	4 / 5
2026-10-13	Unavailable	$860,650,178	4 / 5
2026-10-14	Unavailable	$860,650,178	4 / 5
2026-10-15	Unavailable	$860,650,178	4 / 5
2026-10-16	Unavailable	$860,650,178	4 / 5
2026-10-17	Unavailable	$860,650,178	4 / 5
2026-10-18	Unavailable	$860,650,178	4 / 5
2026-10-19	Unavailable	$860,650,178	4 / 5
2026-10-20	Unavailable	$860,650,178	4 / 5
2026-10-21	Unavailable	$860,650,175	4 / 5
2026-10-22	Unavailable	$858,434,203	3 / 5
2026-10-23	Unavailable	$858,434,203	3 / 5
2026-10-24	Unavailable	$858,434,203	4 / 5

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	6	2	0
2026-06-01	6	2	0
2026-07-01	6	2	0
2026-08-01	6	2	0
2026-09-01	6	2	1
2026-10-01	6	2	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 6 Buy / Strong Buy · 2 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades3 maintains

Recent actions · Sep 25–Oct 24 · 3 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

UBSOct 21 · prior Jul 1

$34.00 → $18.00-47.1%

Piper SandlerOct 19 · prior Sep 8

$9.00 → $8.00-11.1%

Morgan StanleyOct 14 · prior May 19

$41.00 → $34.00-17.1%

$0$22.55$45.10

0 raises · 3 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

reduce losses from -$0.47 EPS in FY 2026 toward breakevenPublished status: Broken
grow revenue from ~$80M in Q3 2026 to >$850M in FY 2027Published status: Broken

Next proof point

Nov 12, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

3.9%Typical daily move · historical

Downside history

-71.2%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

XENERGY INC outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

XE is a speculative, development-stage industrial business whose long-term thesis depends on advancing its small modular reactor and fuel plans. Management has made progress on stated priorities, but the thesis state is insufficient because there is not enough recent financial history to assess it.

What's priced into XENERGY INC

The evidence does not provide a valuation level or clear market expectations, so whether XE is cheap, fair, or expensive versus peers cannot be assessed. The priced-in evidence shows low fragility, but that does not establish what expectations are reflected in the valuation.

What the fundamentals likely do

Over the near term, two recent earnings misses and an elevated risk of another miss point to continued uncertainty. Over the multi-year view, reactor regulatory work, fuel-facility construction, and supply-chain agreements are progressing, though major development and construction work remains.

What XENERGY INC hinges on

The thesis depends on XE continuing to advance Xe-100 approvals and TRISO-X construction on schedule, while building reliable fuel supplies. Near-term conditions also depend on industrial-sector results and economic growth: weaker bellwether performance or GDP growth below 2% would add pressure to this growth-sensitive business.